Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone and Paroxetine for Co-occurring Alcoholism and Depression/PTSD
NCT00338962Phase 3Completed
- Sponsor
- Yale University
- Start
- Oct 2001
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone, paroxetine in alcohol use disorder (AUD), major depressive disorder (MDD), post-traumatic stress disorder (PTSD), sponsored by Yale University. Started Oct 2001; status: completed.
02
Drugs
naltrexoneparoxetine
03
Conditions
alcohol use disorder (AUD)major depressive disorder (MDD)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00338962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338962.